European Union - English - EMA (European Medicines Agency)

hospira uk limited - docetaxel trihydrate - stomach neoplasms; prostatic neoplasms; breast neoplasms; head and neck neoplasms; carcinoma, non-small-cell lung - antineoplastic agents - breast cancertaxespira in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:operable node-positive breast cancer;operable node-negative breast cancer.for patients with operable node-negative breast cancer, adjuvant treatment should be restricted to patients eligible to receive chemotherapy according to internationally established criteria for primary therapy of early breast cancer.taxespira in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.taxespira monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.taxespira combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours over express her2 and who previously have not received chemotherapy for metastatic disease.taxespira in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracycline.non-small cell lung cancer taxespira indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior chemotherapy.taxespira in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small cell lung cancer, in patients who have not previously received chemotherapy for this condition.prostate cancer taxespira in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.gastric adenocarcinoma taxespira in combination with cisplatin and 5-fluorouracil is indicated for the treatment of patients with metastatic gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, who have not received prior chemotherapy for metastatic disease.head and neck cancer taxespira in combination with cisplatin and 5-fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck.

Australia - English - Department of Health (Therapeutic Goods Administration)

bard australia pty ltd - 61564 - central venous catheter electrocardiographic navigation system - the nautilus? e adaptor is a sterile single-use ecg extension cable connected to the catheter?s guidewire/stylet and a separate ecg cable used for nonradiographic central venous catheterisation based on the ecg method.

Australia - English - Department of Health (Therapeutic Goods Administration)

bard australia pty ltd - 61564 - central venous catheter electrocardiographic navigation system - nautilus? s saline adaptor is a sterile single-use ecg extension cable intended to channel blood (drawn from the patient) and saline for purposes of maintaining a saline column for ecg signal conductivity and nonradiographic central venous catheterisation based on the ecg method.

Australia - English - Department of Health (Therapeutic Goods Administration)

teleflex medical australia pty ltd - 61729 - central venous catheter navigation system support kit - the visual positioning system is intended for peripherally inserted central catheter and central venous catheter tip location/guidance and without need for x-ray. the single use ecg pack is part of this system. it includes ecg electrodes and leads, clip, remote cover and may include an adapter.

Australia - English - Department of Health (Therapeutic Goods Administration)

teleflex medical australia pty ltd - 61730 - central venous catheter navigation system control unit - the t piece is a component used in conjunction with the visual positioning system. the t-piece is a low-power magnetic field emitter which tracks the location of the central venous catheter as it approaches the superior vena cava (svc). the track is displayed on the console of the visual positioning system.

Australia - English - Department of Health (Therapeutic Goods Administration)

teleflex medical australia pty ltd - 61730 - central venous catheter navigation system control unit - the visual positioning system is intended to provide real time tip location information of a central venous catheter by utilization of ecg to observe p-wave changes as the tip approaches the right atrium of the heart via the superior vena cava (svc). the system includes a monitor, remote control, patient ecg cable, ecg snap leads and a disposable ecg clip cable.

Australia - English - Department of Health (Therapeutic Goods Administration)

bard australia pty ltd - 61564 - central venous catheter electrocardiographic navigation system - the ecg cable allows signals to be transmitted from the patient to a separate device. the signals are converted into digital data and processed to allow guidance and positioning of a central venous catheter using a separate device.

Australia - English - Department of Health (Therapeutic Goods Administration)

florey medical pty ltd - 61564 - central venous catheter electrocardiographic navigation system - an assembly of noninvasive devices intended to use electrocardiographic (ecg) data to assist guidance and positioning of a central venous catheter [e.g., peripherally-inserted central catheter (picc), central venous catheter (cvc), haemodialysis catheter]. it includes a portable battery-powered control unit, ecg cable(s), and ecg leads(s). the catheter (not included) is used as an intravascular electrode, with the guidewire or intraluminal saline used as a conductor. the control unit processes ecg signals and sends them to a separate off-the-shelf device (e.g., smartphone), whereby intravascular ecg changes indicate catheter position typically in conjunction with skin surface ecg data.

Australia - English - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 61594 - central venous catheterization kit, short-term - a peripherally inserted central venous catheter procedure pack suitable for short-term (<29 days) administration/infusion of intravenous solutions/medicines.

Australia - English - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 61594 - central venous catheterization kit, short-term - a central venous catheter procedure pack intended for short-term (<=29 days)administration/infusion of intravenous solutions/medicines, suitable for access via central venous, peripheral venous or arterial sites.